|The molecular taxonomy of primary prostate cancer|
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
|The evolutionary history of lethal metastatic prostate cancer|
G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ...
Nature 520 (7547), 353-357, 2015
|Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis|
H Cheng, L Zhang, DE Cogdell, H Zheng, AJ Schetter, M Nykter, ...
PloS one 6 (3), 2011
|Critical assessment of automated flow cytometry data analysis techniques|
N Aghaeepour, G Finak, H Hoos, TR Mosmann, R Brinkman, R Gottardo, ...
Nature methods 10 (3), 228, 2013
|Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer|
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
|Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals|
V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ...
Nature immunology 10 (4), 437, 2009
|Evaluation of methods for modeling transcription factor sequence specificity|
MT Weirauch, A Cote, R Norel, M Annala, Y Zhao, TR Riley, ...
Nature biotechnology 31 (2), 126, 2013
|Gene expression dynamics in the macrophage exhibit criticality|
M Nykter, ND Price, M Aldana, SA Ramsey, SA Kauffman, LE Hood, ...
Proceedings of the National Academy of Sciences 105 (6), 1897-1900, 2008
|Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer|
AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ...
JAMA oncology 2 (12), 1598-1606, 2016
|The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma|
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
|A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding|
Q Huang, T Whitington, P Gao, JF Lindberg, Y Yang, J Sun, MR Väisänen, ...
Nature genetics 46 (2), 126, 2014
|Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer|
M Annala, G Vandekerkhove, D Khalaf, S Taavitsainen, K Beja, ...
Cancer discovery 8 (4), 444-457, 2018
|Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer|
KA Leinonen, OR Saramäki, B Furusato, T Kimura, H Takahashi, S Egawa, ...
Cancer Epidemiology and Prevention Biomarkers 22 (12), 2333-2344, 2013
|Driver fusions and their implications in the development and treatment of human cancers|
Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ...
Cell reports 23 (1), 227-238. e3, 2018
|Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer|
AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ...
JNCI: Journal of the National Cancer Institute 109 (12), 2017
|Critical networks exhibit maximal information diversity in structure-dynamics relationships|
M Nykter, ND Price, A Larjo, T Aho, SA Kauffman, O Yli-Harja, ...
Physical review letters 100 (5), 058702, 2008
|Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network|
KM Holmes, M Annala, CYX Chua, SM Dunlap, Y Liu, N Hugen, ...
Proceedings of the National Academy of Sciences 109 (9), 3475-3480, 2012
|Simulation of microarray data with realistic characteristics|
M Nykter, T Aho, M Ahdesmäki, P Ruusuvuori, A Lehmussola, O Yli-Harja
BMC bioinformatics 7 (1), 349, 2006
|Treatment outcomes and tumor loss of heterozygosity in germline DNA repair–deficient prostate cancer|
M Annala, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, ...
European urology 72 (1), 34-42, 2017
|Gene-pair expression signatures reveal lineage control|
M Heinäniemi, M Nykter, R Kramer, A Wienecke-Baldacchino, ...
Nature methods 10 (6), 577, 2013